Top 15 Pharma Companies in India

Indian pharmaceuticals market is expected to be worth USD 33.18 billion and      reach 9th position in the global pharma market by 2023.

1. Sun Pharmaceutical Industries Limited : INR 273.28 Billion
2. Aurobindo Pharma Limited : INR 164.99 Billion
3. Lupin Limited : INR 159.55 Billion
4. Cipla Limited : INR 155.77 Billion
5. Dr. Reddy’s Laboratories : INR 144.36 Billion
6. Cadila Healthcare Limited : INR 120.50 Billion
7. Intas Pharmaceuticals Limited : INR 108.86 Billion
8. Glenmark Pharma Limited : INR 91.86 Billion
9. Torrent Pharmaceuticals Limited : INR 63.01 Billion
10. ManKind Pharma Limited : INR 52.00 Billion
11. Biocon Limited : INR 43.36 Billion
12. Piramal Enterprises Limited : INR 43.22 Billion
13. Wockhardt Limited : INR 40.57 Billion
14. Divis Laboratories Limited : INR 40.26 Billion
15. Abbott India Limited : INR 34.24 Billion

1. Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited is a multinational company and was established by Mr. Dilip Shanghvi in 1983 offering products to treat psychiatry ailments. Today the company offers formulations in various therapeutic areas, such as cardiology, psychiatry, neurology, gastroenterology and diabetology.

Sun Pharmaceutical is India's largest pharmaceuticals company based on 

2. Aurobindo Pharma Limited

Aurobindo Pharma was established in 1986 and it's key business segments are APIs, Formulations and Packaging. Aurobindo Pharma sells over 300 products in over 125 countries. About 35% sales are generated through APIs, and About 65% of the company’s revenue is generated from formulations business, of which 63% of formulation sales comes from United States.

Aurobindo Pharma is India's second largest pharmaceuticals company based on overall revenue. In FY 2018 the company's revenue was INR 164.99 billion which saw an increase of 9.34% over the revenue in FY 2017.

3. Lupin Limited

Lupin was established in 1968 and it's key business segments are APIs and Formulations, and the company manufactures and markets pharmaceutical products in all major markets across the globe. Lupin has a presence in key growth therapies such as Cardiology, Central Nervous System, Diabetology, Respiratory, Gynecology, Anti-Infective, Gastro-Intestinal and Oncology.

Lupin is India's third-largest pharmaceuticals company based on overall revenue. In FY 2018 the company's revenue was INR 159.55 billion which declined by 9.35% compared to revenue in FY 2017.

4. Cipla Limited

Chemical, Industrial & Pharmaceutical Laboratories, now known as Cipla, was incorporated in 1935. Cipla Limited was founded by Dr. K.A. Hamied. Cipla is a therapy leader in India for anti-malarial with a market share of over 34%.

Cipla is India's fourth largest pharmaceuticals company based on overall revenue. In FY 2018 the company's revenue was INR 155.77 billion which saw an increase of 4.83% over the revenue in FY 2017.

5. Dr. Reddy’s Laboratories

Dr. Reddy’s Laboratories is headquartered in Hyderabad and was founded in 1984. The company manufactures and markets a wide range of pharmaceuticals in India and overseas. The company has over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology products.

Dr. Reddy’s Laboratories is India's fifth largest pharmaceuticals company based on overall revenue. In FY 2018 the company's revenue was INR 144.36 billion which saw an increase of 0.48% over the revenue in FY 2017.

6. Cadila Healthcare Limited

Cadila Healthcare Limited was founded in 1952. Zydus Cadila provides total healthcare solutions ranging from formulations, active pharmaceutical ingredients and animal healthcare products to wellness products.

Cadila Healthcare Limited is India's sixth largest pharmaceuticals company based on overall revenue. In FY 2018 the company's revenue was INR 120.50 billion which saw an increase of 24.21% over the revenue in FY 2017.

7. Intas Pharmaceuticals Limited

Intas was founded in 1984. Intas has 13 commercialized biosimilars including Docetaxel & Paclitaxel. As on date, Intas continues its R&D efforts in chronic disease areas such as oncology (cancer), rheumatology, auto-immune, nephrology, ophthalmology and plasma-derived product based therapies. Intas has 14 formulation manufacturing facilities, of which seven are located in India, and the rest in the U.K. and Mexico.

Intas Pharmaceuticals is India's seventh largest pharmaceuticals company based on overall revenue. In FY 2018 the company's revenue was INR 108.86 billion which saw an increase of 29.84% over the revenue in FY 2017.

8. Glenmark Pharma Limited

Glenmark Pharma Limited was founded in 1977. Glenmark is a research-driven organization which is focused on discovering novel molecules and developing high-quality generics for people all around the globe. With a focus towards innovation and a robust growth framework, the company's drug discovery endeavors continue to play a vital role in the therapeutic areas of dermatology, respiratory and oncology.

Glenmark Pharma Limited is India's eighth largest pharmaceuticals company based on overall revenue. In FY 2018 the company's revenue was INR 91.86 billion which saw a decrease of 0.21% over the revenue in FY 2017.

9. Torrent Pharmaceuticals Limited

Torrent Pharmaceuticals Limited was founded in 1959. The company is engaged in manufacturing and marketing of branded and unbranded generic formulations. Currently, the company consumes most of the APIs manufactured in its facility, and only a fraction is sold to the external consumers. Also, the company is engaged in contract manufacturing of formulations for pharmaceutical majors. For the last fifteen years, Torrent Pharmaceuticals has been manufacturing Insulin for Novo Nordisk Indian operations

Torrent Pharmaceuticals is India's ninth largest pharmaceuticals company based on overall revenue. In FY 2019 the company's revenue was INR 63.01 billion which saw an increase of 3.63% over the revenue in FY 2017.

10. ManKind Pharma Limited

ManKind Pharma Limited was founded in 1995. The company is engaged in manufacturing of a wide range of products – Antibiotic, Antifungal, NSAIDs, Gastrointestinal, Anthelmintic, Cardiovascular, Dermal, Erectile Dysfunction, and several other categories.

ManKind Pharma is India's tenth largest pharmaceuticals company based on overall revenue. In FY 2018 the company's revenue was INR 52.00 billion which saw an increase of 16.67% over the revenue in FY 2017.

11. Biocon Limited

Biocon Limited was founded in 1978. From being an enzyme venture, Biocon successfully emerged as a biotechnology company in less than two decades time and now is a fully-integrated Biopharmaceutical company. The parent company’s key subsidiaries are Syngene International Limited, Biocon Biopharmaceuticals Private Limited, Biocon Research Limited, Switzerland-based Biocon SA and Malaysia-based Biocon SDN.BHD. Also, The Company owns 50% stake in Abu Dhabi-based NeoBiocon FZ.

Biocon Limited is India's eleventh largest pharmaceuticals company based on overall revenue. In FY 2018 the company's revenue was INR 43.36 billion which saw an increase of 6.33% over the revenue in FY 2017.

12. Piramal Enterprises Limited

Piramal Enterprises Limited was founded in 1988.The Company is in the pharma, critical care, consumer products, phytomedicine and imaging. For this ranking only the pharmaceuticals division's revenue was considered.

Piramal is India's twelfth largest pharmaceuticals company based on overall revenue. In FY 2018 the company's revenue was INR 43.22 billion which saw an increase of 11.03% over the revenue in FY 2017.

13. Wockhardt Limited

Wockhardt Limited was founded in 1960s. Wockhardt has 3 research centres and 12 manufacturing plants, with businesses ranging from the manufacture and marketing of Pharmaceutical and Bio-pharmaceutical formulations, Active Pharmaceutical Ingredients (APIs) and Vaccines.

Wockhardt Limited is India's thirteenth largest pharmaceuticals company based on overall revenue. In FY 2018 the company's revenue was INR 40.57 billion which saw a decrease of 1.74% over the revenue in FY 2017.

14. Divis Laboratories Limited

Divis Laboratories Limited was founded in 1990. Divis Laboratories business segments are Active Pharma Ingredients, Nutraceuticals and intermediates. The company exports over 90% of manufactured products to foreign countries and only 8%-10% is consumed in India yearly. The company derives nearly 90% of revenues from developed economies such as Europe and US.

Divis Laboratories is India's fourteenth largest pharmaceuticals company based on overall revenue. In FY 2018 the company's revenue was INR 40.26 billion which saw a decrease of 3.70% over the revenue in FY 2017.

15. Abbott India Limited

Abbott India Limited was founded in 1944. Abbott India Limited is public listed company and a subsidiary of Abbott Laboratories USA. Abbott India has headquarters in Mumbai, Maharashtra. The company manufactures pharmaceutical drugs and enjoys strong brand equity multiple therapeutic categories such as Women's Health, Gastroenterology, Neurology, Thyroid, Diabetes, Urology, Pain Management, Vitamins, Anti-Infectives & other therapy areas. Abbott India has a state-of-the-art formulation plant at Verna, Goa designed to produce high quality, high volume formulations.

Abbott India Limited is India's fifteenth largest pharmaceuticals company based on overall revenue. In FY 2018 the company's revenue was INR 34.24 billion which saw an increase of 14.29% over the revenue in FY 2017.

Who are the top 10 pharmaceutical companies in the world? (2020)

The global pharmaceutical industry reached unprecedented heights in 2018, being estimated at an astounding $1.11 trillion. By 2020, this figure is set to rise to $1.43 trillion. With rising pressure to develop drugs to meet ever increasing global demand, pharmaceutical companies continue to work tirelessly to bring the most innovative and cutting-edge treatments to patients.

Being a research-driven industry, approximately $150 billion is spent by pharmaceutical companies every year on research and development projects. Out of thousands of compounds, only a small percentage gain regulatory approval to be used by patients to treat disease and improve quality of life. However, in 2018, a record number of novel drugs developed by pharmaceutical companies across the globe were approved by various regulatory bodies. A large proportion were approved by the US regulatory body, the FDA, which approved 55 novel drugs and smashed its record for generic approvals (781 up from 763 in 2017).

Although the USA’s market share of the global pharmaceutical industry is worth over $341.1 billion, the Chinese, South East Asian, Eastern European and South American markets are beginning to emerge. For example, the Chinese market is rich with preclinical and early-phase drugs, and is a growing nucleus of biotech activity. The next few years will see global growth thanks to the increasing wealth worldwide, as well as increasing demand to maintain high levels of innovation to combat unmet medical need.

Proclinical has ranked the leading pharmaceutical companies according to 2018 revenue from their pharmaceutical segment only. Below is a list of the top 10 biggest pharma companies in the world in 2019:

Bristol-Myers Squibb (BMS) 

US $22.6 billion

A new entry into the top 10 pharma list is Bristol-Myers Squibb, a leading American pharmaceutical company headquartered in New York City. BMS specialises in four key therapy areas: oncology, cardiovascular, immunoscience and fibrosis. The company's strong growth in 2018 can be in part attributed to continued success of leading drugs Opdivo (cancer) and Eliquis (a blood thinner). BMS' success is likely to be further boosted following the company's planned acquisiton of Celgene - an innovative oncology biotech - in early 2019. This strategic acquisition will help position BMS as a leading biopharma player thanks to Celgene's robust pipeline.

GlaxoSmithKline (GSK)

US $23 billion

A staple candidate in the top 10 pharma list year on year, GlaxoSmithKline (GSK) is a leading British pharmaceutical company that always boasts a strong pipeline of innovative drugs. The company specialises in a broad range of therapy areas but is particularly successful in the fields of HIV/AIDS, respiratory and vaccines. The company enjoyed 2% revenue growth compared with 2017 figures, with sales being boosted by GSK’s best-selling HIV drugs Trivicay and Triumeq, the Ellipta inhaler for asthma and COPD and Nucala, another successful asthma treatment. Last year GSK saw the key approval of Shingrix, developed to treat the shingles virus, which was very successful in 2018 as expected, with sales reaching £784 million. In general, growth was slightly offset by steep generic competition in 2018 for various GSK drugs like Seretide, Epizixom and Avodart.

Amgen

US $23.7 billion

Amgen is an American biopharmaceutical company headquartered in California that specialises in developing novel human therapeutics, with a focus on cardiovascular disease, oncology, bone health, neuroscience, nephrology, and inflammation. The company is steadily becoming a permanent fixture on this top 10 list. This change is in part due to the success of various Amgen products, including Repatha (72% increase yoy), BLINCYTO® (31% increase yoy) and Prolia® (16% increase yoy). In early 2019, Amgen was voted one of Fortune Magazine’s Most Admired Companies in the pharmaceutical industry and was listed number 5 on Fast Company's 2019 Most Innovative companies. 

Novartis

US $34.9 billion

One of the leading pharmaceutical companies in Switzerland, Novartis comfortably makes the top 10 pharma list for 2019. The company focuses on a wide range of disease areas including oncology, immunology/dermatology, neuroscience and respiratory. The company's revenue grew by 5.8% compared with 2017 figures despite a few top selling drugs facing generic competition in major markets, such as as oncology success Gleevec, and blood pressure drugs Diovan and Exforge. To combat these losses, Novartis spent 18% of their overall 2017 revenue on research & development in 2018. Currently, Novartis' best selling drugs are Gilenya, for multiple sclerosis, and Lucentis, for patients suffering from eye-degenerative diseases.

Merck & Co 

US $37.7 billion

American pharmaceutical company Merck takes a spot as one of the top 5 pharmaceutical companies in the world in 2018. Merck is known as MSD outside of North America. The company develops drugs, vaccines and biologics in many areas including cardiovascular, oncology, endocrinology and infectious disease. The company saw an impressive 12.2% revenue growth since 2017 with sales boosted by the continued success of Merck’s bestselling drugs: cancer immunotherapy Keytruda, HPV vaccine Gardasil and diabetes pill Januvia. 

Sanofi

US $39.3 billion

4th on the top 10 pharma list is French pharmaceutical company, Sanofi. The company saw 7.1%% revenue growth within its pharmaceutical sector, which contributes a substantial percentage of the company’s total revenue. Over 25% of this revenue came from Sanofi’s three best selling drugs, Lantus, an insulin injection for diabetes, Lovenox, an anticoagulant to prevent blood clots, and Aubagio, the one-daily pill to treat a form of multiple sclerosis. 

Johnson & Johnson 

US $40.7 billion

In the top 3 pharmaceutical companies in the world is Johnson & Johnson, a company that was established over 130 years ago and has become a staple household name thanks to popular consumer goods like Aveeno, Neutrogena and Listerine. The notable 12.1% growth can be in part attributed to its acquisition of biopharmaceutical company Actelion in 2017, which contributed a 3.4% increase in 2018 thanks to its pulmonary arterial hypertension portfolio. Other drivers of growth included best-selling drugs Stelara, Darzalex and Zytiga.

Roche

US $45.6 billion

Swiss pharmaceutical company, Roche, is the 2nd biggest pharmaceutical company in the world for 2019, and employs 94,442 people worldwide. The company develops innovative drugs and devices in a number of key indications, such as oncology, immunology, infectious diseases and neuroscience. Annual growth from the pharmaceutical segment was 2.7% and revenue from the top 3 products contributed over 40% of Roche’s total revenue in 2018 ($57.2 bn). Roche’s best-selling drugs also happen to be in the world’s top cancer drugs: Herceptin, Avastin and Rituxan. Roche's CEO, Severan Schwan reported that new medicines in accounted for 90% of the company's growth in 2018, particularly the launch of Ocrevus, said to be the most successful in Roche's history.

Pfizer

US $53.7 billion

The world’s largest pharmaceutical company is multinational pharma giant Pfizer, headquartered in Connecticut, USA. The research-based company has a varied portfolio that spans many therapy areas, including immunology, oncology, neurosciences and rare diseases. Despite modest revenue growth, Pfizer had a very successful year in 2018. The company received several FDA approvals, particularly in oncology, and many of its best-selling products have many years of patent protection remaining. There was particular growth with some of Pfizer’s key products, including Ibrance, Eliquis and Xeljanz.

Proclinical is a specialist recruitment company operating exclusively in the life science industry. Every day we have new job opportunities arising at top 10 pharmaceutical companies across the globe. Simply upload your CV to start getting matched with pharmaceutical jobs at leading companies that could transform your career.

Ayurvedic Third Party Manufacturing

We Manufacture

Our main aim and objective are to essentially provide our wide range of customers with products with first class quality.

Are you searching for a genuine Ayurveda company for Third Party Manufacturing of Ayurvedic Products? Then your search is over now- Deep Ayurveda- a renowned ayurvedic company and third-party manufacturer & exporter of Ayurveda and herbal products in India. Deep Ayurveda herbal product manufacturing unit situated in Mohali- Punjab (India), which is sponsored & certified by KVIC (Govt. of India) and GMP certified by the Ayush Department of India. Our production facility is well equipped with the most modern state-of-art equipment like- fully automatic capsule filling machine (SA9), liquid filling machine SS316, double cone blender, herbs grinder and pulverizer to produce a various range of herbal capsule, herbal tablet, herbal syrup, herbal powder, and herbal oils. Production unit also in compliance with USFDA regulations & guidelines to meet international standards. Production facility having the capacity to produce one million capsule and 5000 finish bottles of oil & syrup per day in own brand as well as pharmaceutical (contract) third party manufacturing of ayurvedic products in private labeling. We also have adequate repository capabilities for stocking raw herbs for our ayurvedic production. Our cutting edge facilities and trained manpower ensure our capacity in handling the requirements of our customers in a satisfactory manner.

We are also specialized to produce patent & classical ayurvedic medicines for practitioner dispensing, and so far, we’ve patented more than 200+ products and our State of the art manufacturing facility with world-class infrastructure ensures quality standards of medicines we produce.Are you searching for a genuine Ayurveda company for Third Party Manufacturing of Ayurvedic Products? Then your search is over now- Deep Ayurveda- a renowned ayurvedic company and third-party manufacturer & exporter of Ayurveda and herbal products in India. Deep Ayurveda herbal product manufacturing unit situated in Mohali- Punjab (India), which is sponsored & certified by KVIC (Govt. of India) and GMP certified by the Ayush Department of India. Our production facility is well equipped with the most modern state-of-art equipment like- fully automatic capsule filling machine (SA9), liquid filling machine SS316, double cone blender, herbs grinder and pulverizer to produce a various range of herbal capsule, herbal tablet, herbal syrup, herbal powder, and herbal oils. Production unit also in compliance with USFDA regulations & guidelines to meet international standards. Production facility having the capacity to produce one million capsule and 5000 finish bottles of oil & syrup per day in own brand as well as pharmaceutical (contract) third party manufacturing of ayurvedic products in private labeling. We also have adequate repository capabilities for stocking raw herbs for our ayurvedic production. Our cutting edge facilities and trained manpower ensure our capacity in handling the requirements of our customers in a satisfactory manner.

We are also specialized to produce patent & classical ayurvedic medicines for practitioner dispensing, and so far, we’ve patented more than 200+ products and our State of the art manufacturing facility with world-class infrastructure ensures quality standards of medicines we produce.

Third Party Manufacturing Pharma of Herbal Products:

Research & Development:

R&D department for the product development of a new formulation for pharma third party manufacturing of Ayurvedic products as well as testing of raw material and finished Herbal medicine for third party manufacturing pharma and also associated with the renowned lab of India.

• Pharmacognosy- To identify authentication raw materials through Microscopic and Macroscopic methods.
• Chemistry – To ensure pre-process, in-process and post-process quality standards of every product.
• Pharmaceutics- To ensure new formations, presentations and optimum dosage for each medicine.
• Microbiology-To ensures the absence of microbial contamination in ayurvedic products, to standardize fermentation, to identify herbs have good antibacterial & antifungal properties.
• Pharmacology-To scientifically evaluates the efficacy, toxicity, and dosage of herbal formulations.
• Clinical Research – To conduct various phases of clinical trials on an actual patient at our clinics using Epidemiological parameters.

Our Product USP:

• In our formulation, we used herbs extracts in appropriate quantity which is mentioned on the label.
• Used higher concentrated pure and standardized herbal extracts (10:1)
• Product formulated by qualified and experienced Ayurveda Doctor.
• No added synthetic colors, chemicals, and artificial flavoring agents.
• Efficacy has been already tested and proved during clinical trials.
• Using since 2008 in our clinical practice.

PANACEA BIOTECH LTD

Company Profile

The word “panacea” is derived from Greek mythology, where the same is believed to be the goddess of universal remedy. Panacea Biotech Limited provides remedies, has the facilities of Research and is one of the pioneers of health management companies.

It develops pharmaceutical products, vaccines and markets the same to the end users vide the distributors, the retailers and wholesaler. It started its journey in the year 1984 and in the year 1995 it got listed and attained the stature of a Limited Organization. Currently they boast of five research centers across the country which excels in the fields of biotechnology, biopharmaceutics, pharmaceuticals and natural products. It is believed to be the biggest vaccine manufacturing company of the country.  Its most famous achievement is the Polio vaccine which is believed to be implemented in about thirty countries very soon. The several noticeable feats of the company includes the first patent of product in the year 1997, Research and development tie up with an European Organization in 2001, signing an agreement for the commercialization and development of the Anthrax Vaccine and also the Japanese Encephalitis vaccine.  A number of collaborations and joint ventures have also strengthened the functioning of the firm. It has the significant achievement of having the WHO prequalification for the Pentavalent vaccine.

1)    Products and services Offered

Apart from the manufacturing of vaccines, and research studies, the company also concentrates on the fields of Nephrology which includes the organ transplantation and dialysis management, Diabetology, Gastroenterology, Orthopedic, Oncology and respiratory.  For all the segments, a specific Strategic Business Unit has been set up for providing treatments and suitable drugs in the respective fields. All the brands that have been set up have established a special reputation of their own in the world of pharmaceuticals.  The patented drugs have also been able to get hold of the confidence of the patients. The Value India Healthcare is an initiative which provides a complete basket of medicine that is needed sporadically by the doctors to prescribe for their patients. The Pain killers, the Vitamins, the antibiotics all are a part of the basket. The agreement with      PT BioFarma has also facilitated them to manufacture the vaccine of measles. They have planned to send the same to various countries to reduce the measles on a global basis.

2)    Awards

The pioneer pharmaceutical company has achieved a lot since its inception in the year 1984. The first organization to come up with fully liquid vaccine received the prequalification of WHO. Enivac vaccines are also World Health Organization prequalified drug that is in use in many other countries. The company was named the third largest biotechnology company of the country in the ABLE survey in 2011. This also featured in the top 50 pharma companies listed by ORG IMS. The latest feather in the cap was added by the firm when the brand PacliALL received the best product of the year award.

3)    Careers

It needs no more mention of the achievements of this reputed company.  The dream for any student, starting his career would be to work with such a pioneer. Panacea Biotech limited has the perfect blend of youth and the experienced to guide the freshers and the experienced alike. The students with their bachelor degree in Pharma, or micro biology can really look forward to join such an elite firm.  The quality training programs offered by the company is one of the alluring aspects to a fresher.

SERUM INSTITUTE OF INDIA LTD

Company Profile

The journey of Serum Institute of India Ltd started in the year 1966 under the proficient guidance of Mr Cyrus Poonawala. He developed the Organization with the purpose of manufacturing life saving immunizing medicines, which at that point in time was not available to the common man since most were imported and OUT of the grab of the common man.


OVER PERIOD OF TIME  it achieved the initial target by manufacturing enough drugs, which brought anti tetanus, and anti snake venom serum within the reach of the people. Slowly and steadily the vaccines for Diptheria, Tetanus and Pertusis followed by the vaccines for the measles, mumps and Rubella also found its presence in the market courtesy this firm. With the passage of time it grew up to be one of the largest manufacturers of vaccines. The fangs of diseases like BCG, r- Hepatitis B, Tetanus , Rubella, Measles and Mumps were busted by the vaccines manufactured by the company. All the vaccines manufactured by them are accredited by the World

Health Organization and are currently used in the immunization programs in about 140 nations across the globe. The first acquisition of a Dutch pharmaceutical giant, Bilthoven Biologicals proved to be a great beneficial proposition for the company. That ensured the expertise and the technology for the Injectable Polio vaccine. The acquisition also changed the pediatric vaccine segment of the company towards the better. The infrastructure has seen a sea change over the years. Today this pioneer can boast of large bio reactors which help manufacture 2 to 4 million doses of vaccine. The tunnel systems, washing, filling and sealing assure a speed of 500 containers per minute. The robotic arm for virus handling, and the automatic inspection facility self explains modernization of the processes. There is no denial to the fact that quality is the key attribute that the company offers for all its products and services.

Products offered

The Organization manufactures a plethora of vaccines and has set up several brands that the doctor prescribes for the patients. A large number of medicines under the bacterial vaccine, the viral vaccine, the recombinant vaccine, the combination vaccine and the meningococcal A conjugate vaccine are produced by them. Gradually they have found a firm footing in the export market as well. Most of the medicines are now exported in huge volumes. They also market a host of products that includes the injections, the tablets and the gels. Whatever the organization offers, quality of the same is world class.

Awards and Credentials
The wall of fame of this company looks filled up. It has received several awards which includes the “Excellence in Inter American public health”, “No 1 Biotech Company of the year” from 2006-2009, “Export excellence award for 96-97 and 97-98” awarded by the DGFT. The list doesn’t end here. It has received several awards for excellence in the field of Exports from various bodies.

Careers The fact that around 65% of the children around the globe receive at least a dose of the Serum Institute of India Ltd speaks about the success story of the company. Apart from the establishment, there are other reasons as well to choose a career in this company. The team work and the employee employer camaraderie is excellent. The seniors guide the juniors in every way possible. All these make up for a beautiful working environment within the company. The opportunity to learn and upgrade is another key factor for joining the organization. More youngsters with the relevant education background are joining the company.

NOVOZYMES SOUTH

1)    Company Overview

The rich history of this organization dates back to 1925, when two brothers Harald and Thorvald together established the laboratory. Ninety years hence, the firm stands tall with the reputation of being one of the largest biotech companies having expertise in industrial biotechnology.

It is also a renowned manufacturer of enzymes. The modern day organizations make it a point to implement biotechnology for the cost savings and reduction in raw material cost. This triggers and explains the importance and success of Novozymes South. They provide the total bio solution to various corporate.

The sustainability of a product completely depends on the constituting elements. The organization offers bio solutions which helps to substitute chemicals and improve the quality of the product. The harmful carbon emissions, which is a great source of concern for the factories across the world and a grave danger to environment and mankind is also reduced by the solutions provided.

The research wing of the unit is ever active and formidable. They detect the right microorganism which helps in narrowing down on the right enzymes. The biopolymers are also used by them to manufacture the ideal enzyme.

Over the years, it has mastered the concept of industrial biotechnology and mustered patrons all across the world. It accounts for almost 48% of the market share of the enzymes. Today, more than 6000 employees work with this esteem company which has more than 6000 patents to its credit.

2)    The products and services

The company offers biosolutions to its customer in various fields which include the household care, food and beverages, bio energy, pulp and paper and the textile. The solutions provided by them clearly make a point to improve the quality of product and the impact of manufacturing on the environment. The enzymes produced and used in the industries ensure a bio friendly process of manufacturing for the different Organization. Wastewater treatment and sustainable farming are two more prominent highlights of the solution provided. The farmers have been benefitted to a great extent by the use of the pesticide made out of enzymes. The same has led to a healthier and better crop in terms of the yields. The animal nutrition is also bettered. Biopharma is another sector where the organization has had huge contributions. They have provided biological based technologies and products to bolster the quality of the drugs. Hyaluronic acid, enzymes and recombinant albumin are some of the examples of the biological based products.

3)    The awards and the recognition

The organization has been a witness to many awards and credentials over the last century. The prizes for the best CSR policy and the best biofuels leadership are only couple of them. It has also achieved a tax credit from Mr Obama, which is praise worthy. The recognition of the company amongst its patrons is beyond the periphery of doubt.

4)    Careers

The organization has set up offices all across the world. Novozymes South Asia Pvt ltd is an office set up in Bangalore India. It is a great opportunity for the youngsters and the experienced to work with an organization of such healthy repute. The excellent working environment and the cohesiveness that reflects in the teamwork, explains the desire for professionals to join this organization. Opportunity to learn is exceptional and is one of the key factors to select Novozymes South as the employer.

INDIAN IMMUNOLOGICALS

1)    Company overview

Indian Immunologicals is an Organization which not only caters the healthcare solutions to the mankind but also look after the health issues of the animals with equal expertise.

In the year 1982, the organization was set up by the National Dairy Development Board. The prime objective was to provide the Foot and Mouth disease vaccines to the farmers at affordable prices. It re-tasted success with the launch of tissue culture vaccine after the launch of foot and mouth disease. Since then the company has launched a plethora of vaccines and has spread its operations in the field of veterinary science.

Today, it boasts of having set up one of the largest plants in the world for the veterinary vaccines. Almost all the vaccines for the animals have received the certification from World Health Organization.

The prime objective of the company is not only to render services and products for the betterment of the livestock but also to maximize the technological aid to serve the people of the country.  They have revolutionized the modern biotechnology to provide the best healthcare to the people at affordable prices.

The wonderful Research and Development set up has contributed a great deal towards the blossoming of the organization. The company holds the distinctive feat of being the first Organization in India, and only the second in the World to come up with the rabies vaccine to be used in human beings. It has also made significant progress in the animal bite treatments. T

here is not an iota of doubt that the Organization has already achieved a lot in the field of human vaccines and the animal vaccines, but that has not stopped the organization to aim even higher not only in terms of business but also to support the common people with more established healthcare solutions at pocket friendly prices.

2)    Products and Services

The company excels in the field of human medicines as well as veterinary drugs. It has already come up with a wide range of medicines and vaccines in both the segments. The diagnostics and the vaccines offered by the company is primarily divided into the Human vaccines that features the Oral cancer vaccines, the Pediatric vaccines ,the Flaviviral vaccines and the Picornavinal vaccines and the veterinary vaccines that includes toxoid vaccines, viral vaccines and many more. The company has set up various collaborations, both nationally and internationally to provide drugs at affordable costs. The research team constantly works to develop new recombinant vaccines, the bacterial infections and the conventional vaccines.

3)    Awards and Recognition

The esteem Organization is recognized for achieving many feats. It was the first to manufacture rabies vaccination. Currently this is the third largest company in animal healthcare. The firm is also known for having the largest veterinary vaccine plant.

4)    Careers

The Organization provides the perfect opportunity to the bright students having relevant education background. The working atmosphere is the perfect environment for anyone to flourish. The helping attitude of the seniors towards the juniors helps them to be groomed.